The confirmatory IGNYTE-3 trial is assessing RP1 in combination with nivolumab in patients with advanced melanoma who have progressed on anti-PD-1 and anti-CTLA-4 therapies or are ineligible for ...
The Indiana County Conservation District has launched a new tool for the submission of permits to their office for review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback